Cerebras Systems Inc.
NASDAQ:CBRSSemiconductors
+$19.07 today
- Market cap
- $21.33B
- Beta
- 0.00
- P/E (TTM)
- 210.7
- EPS (TTM)
- $1.10
Volume 12.77M
Average 8.03M
CBRS Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Cerebras Systems Inc.NASDAQ: CBRS
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization of $40.19M in Q3 FY2026
Q3 FY2026 depreciation & amortization was $40.19M. Over 3 fiscal years it compounded at +42.4% a year.
Context
- Depreciation & amortization amounted to 6.8% of revenue in FY2025, up 2.8 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 34.45M USD
- Year-over-year change
- +198.6%
- 3-year CAGR
- +42.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 34.45M | +198.6% |
| FY2024 | 2024-12-31 | 11.54M | +9.0% |
| FY2023 | 2023-12-31 | 10.58M | -11.4% |
| FY2022 | 2022-12-31 | 11.94M | — |
Depreciation & Amortization vs competitors
How CBRS compares with its peers on the latest reported figures
- CBRS's FY2025 depreciation & amortization of $34.45M is the 6th largest of the 7 companies compared; the peer median is $1.56B.
- Its year-over-year change of +198.6% is the highest of 7, against a peer median of +49.6%.
- Depreciation & amortization amounts to 6.8% of revenue for CBRS, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $5.25B | +162.6% | +494.2% | 53.1% | |
| LTM Jul 2026 | $3.69B | +60.2% | +22.6% | 1.2% | |
| LTM Jun 2026 | $3.03B | -0.5% | -11.0% | 7.3% | |
| LTM Jun 2026 | $90.27M | +54.7% | +37.3% | 0.2% | |
PENGPenguin Solutions, Inc. | LTM Aug 2026 | $50.18M | -10.8% | -11.2% | 2.9% |
| FY2025 | $34.45M | +198.6% | +42.4% | 6.8% | |
| LTM Mar 2026 | $1.19M | +44.4% | -24.3% | 2.9% | |
| Peer median (excluding CBRS) | $1.56B | +49.6% | +5.8% | 2.9% | |
Competitors are the stored peer set for CBRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (177.72M) | (127.16M) | (481.6M) | 237.83M |
| Depreciation & Amortization | 11.94M | 10.58M | 11.54M | 34.45M |
| Deferred Income Tax | 114K | 18K | 0 | 0 |
| Stock-Based Compensation | 16.88M | 26.63M | 58.56M | 49.77M |
| Change in Working Capital | (36.63M) | 6.72M | 443.47M | (15.64M) |
| Accounts Receivables | 4.24M | (3.04M) | (130.67M) | 87.01M |
| Inventory | (37.5M) | (25.19M) | (144.97M) | 63.31M |
| Accounts Payables | 250K | 9.78M | 9.01M | 21.15M |
| Other Working Capital | (3.62M) | 25.17M | 710.1M | (187.11M) |
| Other Non-Cash Items | 21.02M | 4.23M | 420.01M | (316.46M) |
| Operating Cash Flow | (164.4M) | (78.98M) | 451.98M | (10.05M) |
| Capital Expenditures | (10.46M) | (6.59M) | (23.44M) | (382.74M) |
| Acquisitions (Net) | 24K | 0 | 0 | 0 |
| Purchases of Investments | (207.23M) | (265.59M) | (302.9M) | (525.41M) |
| Sales of Investments | 355.06M | 353.89M | 309.55M | 240.58M |
| Other Investing Activities | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 137.39M | 81.7M | (16.79M) | (667.58M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 12.99M | 6M | 27.72M | (32.05M) |
| Common Stock Repurchased | (3.88M) | (63K) | (102K) | (38.09M) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (224K) | 13.41M |
| Financing Cash Flow | 9.1M | 5.93M | 112.3M | 1.03B |
| Effect of Forex Changes | (331K) | (73K) | (304K) | (521K) |
| Net Change in Cash | (18.24M) | 8.58M | 547.19M | 348.41M |
| Free Cash Flow | (174.87M) | (85.57M) | 428.54M | (392.79M) |
Cerebras Systems Inc.
NASDAQ:CBRS
Intrinsic Alpha fair value
Locked
Current Price
$94.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.